US Broker Ratings

89bio, Inc. (ETNB) Stock Analysis: Potential 191% Upside Captivates Investors

For investors with a keen eye on the biotechnology sector, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing opportunity. This clinical-stage biopharmaceutical company, which operates from its..

SS Innovations International (SSII): A Rising Star in Healthcare Robotics with 40.8% Revenue Growth

SS Innovations International, Inc. (SSII), a pioneering entity in the healthcare sector, is making significant strides in the medical devices industry, specifically in the field of..

Progyny, Inc. (PGNY) Stock Analysis: Uncovering a 20.97% Upside Potential in Healthcare Plans

Progyny, Inc. (NASDAQ: PGNY) stands out as a key player in the healthcare sector, specifically in the healthcare plans industry. With its headquarters in New York,..

Integra LifeSciences Holdings (IART) Stock Analysis: Navigating a 30.88% Potential Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a stalwart in the medical devices industry, presents a compelling narrative for investors intrigued by both challenges and opportunities within..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Uncovering a Potential 42.88% Upside

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, stands as a compelling opportunity for investors eyeing the medical care facilities industry...

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Biotech with 253% Upside Potential

Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage biotechnology firm specializing in neuromuscular disease therapeutics, presents a compelling investment opportunity for those interested in the healthcare sector...

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Impressive Revenue Growth Fuels a 31% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a key player in the healthcare sector specializing in the development and marketing of branded and generic pharmaceuticals, has caught the..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Biotech Firm with 128% Upside Potential

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a San Diego-based clinical-stage biotechnology company, is capturing significant attention in the healthcare sector with its innovative approach to treating rare..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook with a Promising 25.63% Upside Potential

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotechnology company, has recently caught the attention of investors with its promising potential upside. Specializing in therapies for autoimmune..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Promising 25.89% Upside Potential for Investors

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is making significant strides with its genetic..

GoodRx Holdings (GDRX): Investor Outlook on a Promising 66% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands at the intersection of healthcare and technology, leveraging its innovative platform to offer price comparisons and savings on prescription drugs—a..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Through a Challenging Landscape in the Healthcare Sector

BGM Group Ltd. (BGM), a notable player in China’s healthcare sector, specializes in manufacturing and distributing active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivatives. With..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Can This Healthcare Provider Reach Its 10.45% Upside Potential?

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a key player in the U.S. healthcare industry, has been garnering attention for its expansive home care services catering to..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a Potential 107% Upside Amid Vaccine Innovations

Novavax, Inc. (NVAX) is capturing the attention of investors as a prominent player in the biotechnology sector, riding a wave of remarkable revenue growth while striving..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Unpacking a 50.90% Potential Upside in the Cell and Gene Therapy Sector

BioLife Solutions, Inc. (NASDAQ: BLFS) stands at the forefront of the healthcare sector, particularly within the niche of medical instruments and supplies. Specializing in bioproduction products..

QuidelOrtho Corporation (QDEL) Stock Analysis: Is a 59% Upside Within Reach?

For investors focusing on healthcare opportunities, QuidelOrtho Corporation (NASDAQ: QDEL) presents an intriguing prospect. As a prominent player in the medical devices industry, QuidelOrtho offers a..

Omnicell, Inc. (OMCL)

⚠️ No article content returned.

..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 56% Potential Upside in the Life Sciences Sector

Azenta, Inc. (NASDAQ: AZTA), a significant player in the healthcare sector, specifically within medical instruments and supplies, has caught the attention of investors with a notable..

Beam Therapeutics Inc. (BEAM) Investor Outlook: Exploring a 174% Potential Upside in Biotechnology

For investors seeking opportunities in the dynamic field of biotechnology, Beam Therapeutics Inc. (NASDAQ: BEAM) presents an intriguing case. Founded in 2017 and headquartered in Cambridge,..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Biotechnology Innovator with a 90% Upside Potential

MoonLake Immunotherapeutics (NASDAQ: MLTX) is drawing significant attention in the biotechnology sector with its promising pipeline of therapies targeting inflammatory skin and joint diseases. Founded in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds